Exosomics’ Chairman of the Board Behzad Mahdavi at the EV-based Diagnostics, Delivery & Therapeutics Conference 2020 February 17 in Coronado Island (CA) gave a keynote on exosomes and shared insights into how to develop a winning strategy for its manufacturing and characterization.

Accordo innovativo tra Exosomics & LCM Genect. Una porta aperta sul futuro.

Exosomics & LCM Genect.
Quando l’innovazione made in Italy si unisce, la medicina di precisione supera i confini.

Strategic partnership between Exosomics and NanoFCM for advanced extracellular vesicles-related services to Pharma/Biotech and Academic groups!

Claudio Corallo, Head of Translational Science & Med Affairs at Exosomics, gives a compelling Company Presentation and interview at the Toscana Life Sciences Day.

Exosomics announces the launch of the ExoRef™ line of products.

Exosomics’ Chairman of the Board, Behzad Mahdavi PhD/MBA presents the diagnostic aspects of Exosomes at Phacilitate in Miami, FL on Jan 24.

Standardization of Blood Collection and Processing for the Diagnostic Use of Extracellular Vesicles

Exosomics appoints Kamran Tahamtanzadeh as Chief Commercial Officer based in the Bay Area

Exosomics Announces Its First World-Renowned Scientific and Clinical Advisory Board Member Appointment by Welcoming Dr. Ruggero De Maria, MD, PHD

Exosomics Team is proud to announce the achievement of the ISO 9001:2015 certification

Exosomics Siena earns Frost & Sullivan’s 2018 Europe Enabling Technology Leadership Award in the exosome-based liquid biopsy market.

Lonza Announces Exosomics’ Launch of first RUO Products

Exosomics hosts circRTrain’s next network meeting from May 21-25, 2018 in Siena, Italy!

Our Science and Case Studies

Lonza Invests to Develop Exosomes for Next-Generation Life-Science Applications